How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The prefrontal cortex (PFC) provides 'top-down', higher-order guidance of thought, attention, behaviour and emotion, with dorsolateral regions regulating cognition, and ventromedial regions regulating ...